Cargando…

Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?

A long time ago, the links between renal disease and malignancy were observed, however, quite recently, their importance was recognized and ‘new’ subspecialty in nephrology, namely ‘onconephrology’ was established. In the XXI century, patients with malignancy make up the most growing number of the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Małyszko, Jolanta, Kozlowski, Leszek, Kozłowska, Klaudia, Małyszko, Maciej, Małyszko, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630441/
https://www.ncbi.nlm.nih.gov/pubmed/29029541
http://dx.doi.org/10.18632/oncotarget.18094
_version_ 1783269228110938112
author Małyszko, Jolanta
Kozlowski, Leszek
Kozłowska, Klaudia
Małyszko, Maciej
Małyszko, Jacek
author_facet Małyszko, Jolanta
Kozlowski, Leszek
Kozłowska, Klaudia
Małyszko, Maciej
Małyszko, Jacek
author_sort Małyszko, Jolanta
collection PubMed
description A long time ago, the links between renal disease and malignancy were observed, however, quite recently, their importance was recognized and ‘new’ subspecialty in nephrology, namely ‘onconephrology’ was established. In the XXI century, patients with malignancy make up the most growing number of the subjects seen for nephrology consult and/or critical care nephrology services. A plethora of renal problems may be found in patients with malignancy. They may influence not only their short-term outcomes but also the adequate therapy of the underlying oncological problem. Thus, all these kidney-related issues pose an important challenge for both specialities: oncology and nephrology. In the review a spectrum of acute and chronic renal injury caused by the malignancy is presented as well as the associations between renal disease and cancer. Assessment of kidney function and its importance in patients with malignancy is also discussed as medical oncologists should check the appropriate dose of chemotherapeutic drugs in relation to the actual renal function before prescribing them to the patients. Moreover, effects of kidney function on outcomes in oncology is presented. In addition, nephrology services should better understand both the biology of malignancy with its treatment to become a valuable part treating team to yield the best possible outcome. It is important for nephrology services to be acknowledged and to take an active participation in care of oncology patients.
format Online
Article
Text
id pubmed-5630441
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56304412017-10-12 Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine? Małyszko, Jolanta Kozlowski, Leszek Kozłowska, Klaudia Małyszko, Maciej Małyszko, Jacek Oncotarget Review A long time ago, the links between renal disease and malignancy were observed, however, quite recently, their importance was recognized and ‘new’ subspecialty in nephrology, namely ‘onconephrology’ was established. In the XXI century, patients with malignancy make up the most growing number of the subjects seen for nephrology consult and/or critical care nephrology services. A plethora of renal problems may be found in patients with malignancy. They may influence not only their short-term outcomes but also the adequate therapy of the underlying oncological problem. Thus, all these kidney-related issues pose an important challenge for both specialities: oncology and nephrology. In the review a spectrum of acute and chronic renal injury caused by the malignancy is presented as well as the associations between renal disease and cancer. Assessment of kidney function and its importance in patients with malignancy is also discussed as medical oncologists should check the appropriate dose of chemotherapeutic drugs in relation to the actual renal function before prescribing them to the patients. Moreover, effects of kidney function on outcomes in oncology is presented. In addition, nephrology services should better understand both the biology of malignancy with its treatment to become a valuable part treating team to yield the best possible outcome. It is important for nephrology services to be acknowledged and to take an active participation in care of oncology patients. Impact Journals LLC 2017-05-23 /pmc/articles/PMC5630441/ /pubmed/29029541 http://dx.doi.org/10.18632/oncotarget.18094 Text en Copyright: © 2017 Małyszko et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Małyszko, Jolanta
Kozlowski, Leszek
Kozłowska, Klaudia
Małyszko, Maciej
Małyszko, Jacek
Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
title Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
title_full Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
title_fullStr Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
title_full_unstemmed Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
title_short Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
title_sort cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630441/
https://www.ncbi.nlm.nih.gov/pubmed/29029541
http://dx.doi.org/10.18632/oncotarget.18094
work_keys_str_mv AT małyszkojolanta cancerandthekidneydangereouxliasonsorpricepaidfortheprogressinmedicine
AT kozlowskileszek cancerandthekidneydangereouxliasonsorpricepaidfortheprogressinmedicine
AT kozłowskaklaudia cancerandthekidneydangereouxliasonsorpricepaidfortheprogressinmedicine
AT małyszkomaciej cancerandthekidneydangereouxliasonsorpricepaidfortheprogressinmedicine
AT małyszkojacek cancerandthekidneydangereouxliasonsorpricepaidfortheprogressinmedicine